DENVER, March 08, 2017 -- Global CBD cannabis innovator Elixinol has announced the launch of Respira, a versatile, full-spectrum cannabidiol (CBD) tincture line.
Photos accompanying this announcement are available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/802dcf21-081a-4a7a-8b3f-0296cd7f69e6
http://www.globenewswire.com/NewsRoom/AttachmentNg/3c75f9df-ec94-4722-a0f9-5645e457d5bd
http://www.globenewswire.com/NewsRoom/AttachmentNg/65cb132e-206e-47e4-8f54-42bbcd1c3b4d
http://www.globenewswire.com/NewsRoom/AttachmentNg/cfa76333-fc69-49d1-9e69-75a688e06670
Elixinol has developed Respira with all natural ingredients, making Respira a multi-purpose CBD product suitable for consumption orally, topically, or by vape.
As CBD gains in popularity as a cannabis product without psychoactive properties, consumers are seeking ways to incorporate CBD into their daily lives including topical, digestive and vape oil.
“Respira is our most versatile tincture to date, the customer has complete control over the delivery mechanisms,” said Chris Husong, Director of Marketing and Sales of Elixinol. “As cannabis and CBD customers become more educated, we will continue to develop convenient, high-quality products designed for how our customers are using CBD today.”
Each 10 mg serving size of Respira delivers high concentrations of either 300 mg or 600 mg of CBD oil. Respira is sold in two refreshing flavors, grape-mint and natural.
“I use Respira to ease anxiety, pain and headaches associated with my chronic traumatic encephalopathy (CTE). I can use this as a vape oil in my vape pen when I’m on the go,” said CBD advocate and New York Giants Super Bowl champion Leonard Marshall. “This is a product formulated for busy people like me, and it allows me to be my best me.”
About Elixinol:
Colorado-based Elixinol, founded by Paul Benhaim, hemp entrepreneur since 1991, is widely regarded as one of the most influential CBD brands in the world. With a proven track record of growing and manufacturing high-quality hemp, Elixinol also conducts rigorous laboratory testing and quality control. A global leader in hemp distribution, Elixinol distributes CBD products globally in the United States, Japan, Puerto Rico and the UK. More information is available at Elixinol.com.
Media Contact: Chris Husong Elixinol 844-804-3504 ext 420 [email protected]


American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



